FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 21892160 · Received April 23, 2025

Report

Report Number
1823260-2025-01245
Event Type
Malfunction
Date Received
April 23, 2025
Date of Event
April 3, 2025
Report Date
July 22, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

COMPLETE NAME FOR MEDWATCH FIELD E1 INITIAL REPORTER ESTABLISHMENT NAME: (B)(6). THE COBAS C 503 ANALYTICAL UNIT SERIAL NUMBER IS (B)(6). THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

SECTION D, DEVICE IDENTIFICATION WAS UPDATED. RELEVANT FIELDS OF SECTIONS D AND G WERE UPDATED. THE CREATININE PLUS VER.2 REAGENT LOT NUMBER IS 853138, AND THE EXPIRATION DATE IS 31-OCT-2025. A FIELD SERVICE ENGINEER (FSE) DISCOVERED BUILD-UP ON A SAMPLE PROBE. THE FSE VERIFIED ADJUSTMENTS AND THE GEAR PUMP PRESSURE, AND DECONTAMINATED THE SAMPLE PROBE. QC AND CALIBRATION WERE PASSING BEFORE THE EVENT, SO A GENERAL REAGENT ISSUE IS UNLIKELY. THE INVESTIGATION DETERMINED THAT THERE WERE NO INDICATORS OF PRODUCT-RELATED ISSUES IDENTIFIED.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE CREATININE PLUS VER.2 RESULTS FROM THE COBAS C 503 ANALYTICAL UNIT, RESULTS WERE PROVIDED FOR 1 PATIENT. THE INITIAL RESULT WAS 208 UMOL/L, AND THE REPEAT RESULT ON ANOTHER ANALYZER WAS 62.8 UMOL/L. THE INITIAL RESULT WAS QUESTIONED BY THE PATIENT AND WAS THEN REPEATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1258233 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 853138

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown